HomeProductsBioactive CompoundsMetabolic EnzymesHydroxylaseTelotristat Ethyl
Chemical structure of CAS 1033805-22-9

Telotristat Ethyl

CAS No.1033805-22-9
MDL No.MFCD18251583
MFC27H26ClF3N6O3
MW575.00
InChI KeyMDSQOJYHHZBZKA-GBXCKJPGSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1033805-22-9
Product NameTelotristat Ethyl

Biological Targets

TPH2·TPH1

Associated Conditions

liver disease·neuroendocrine neoplasm·carcinoid heart disease·biliary tract cancer·Diarrhea·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease.

Journal of medicinal chemistry • Vol. 64, Issue 2 • 2021
PMID: 33417443DOI: 10.1021/acs.jmedchem.0c01560

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • Vol. 35, Issue 1 • 2017
PMID: 27918724DOI: 10.1200/JCO.2016.69.2780

Telotristat ethyl: a new option for the management of carcinoid syndrome.

Expert opinion on pharmacotherapy • Vol. 17, Issue 18 • 2016
PMID: 27817224DOI: 10.1080/14656566.2016.1254191

Documentation

Similar Products